ATR
AptarGroup, Inc.NYSEHealthcare$126.01-0.58%ClosedMarket Cap: $8.11B
As of 2026-04-06
Valuation
P/E (TTM)
20.66
PEG
4.27
P/B
3.07
P/S
2.15
EV/EBITDA
11.11
DCF Value
$191.52
FCF Yield
3.6%
Div Yield
1.5%
Margins & Returns
Gross Margin
29.6%
Operating Margin
13.5%
Net Margin
10.4%
ROE
14.7%
ROA
10.0%
ROIC
9.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $962.7M | 20.4% | $112.4M | $74.3M | $1.13 | $0.48 |
| FY 2025 | $3.78B | 29.6% | $510.9M | $392.8M | $5.89 | $1.83 |
| Q3 2025 | $961.1M | 29.9% | $139.1M | $127.8M | $1.92 | $0.45 |
| Q2 2025 | $966.0M | 30.8% | $146.0M | $111.7M | $1.67 | $0.45 |
| Q1 2025 | $887.3M | 37.9% | $113.4M | $78.8M | $1.17 | $0.45 |
| Q4 2024 | $848.1M | 38.8% | $120.1M | $100.9M | $1.49 | $0.45 |
| FY 2024 | $3.58B | 37.8% | $496.5M | $374.5M | $5.53 | $1.72 |
| Q3 2024 | $909.3M | 38.6% | $138.3M | $100.0M | $1.48 | $0.45 |
| Q2 2024 | $910.1M | 37.6% | $126.0M | $90.5M | $1.34 | $0.41 |
| Q1 2024 | $915.4M | 36.3% | $112.1M | $83.1M | $1.23 | $0.41 |
| Q4 2023 | $838.5M | 37.2% | $84.2M | $62.4M | $0.93 | $0.41 |
| FY 2023 | $3.49B | 36.2% | $404.0M | $284.5M | $4.25 | $1.58 |